These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36624344)

  • 1. SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs.
    Han AX; Toporowski A; Sacks JA; Perkins MD; Briand S; van Kerkhove M; Hannay E; Carmona S; Rodriguez B; Parker E; Nichols BE; Russell CA
    Nat Genet; 2023 Jan; 55(1):26-33. PubMed ID: 36624344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs.
    Han AX; Toporowski A; Sacks JA; Perkins MD; Briand S; van Kerkhove M; Hannay E; Carmona S; Rodriguez B; Parker E; Nichols BE; Russell CA
    medRxiv; 2022 Sep; ():. PubMed ID: 35664998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing an integrated national influenza platform for genomic surveillance of SARS-CoV-2 in Ghana: a molecular epidemiological analysis.
    Asante IA; Hsu SN; Boatemaa L; Kwasah L; Adusei-Poku M; Odoom JK; Awuku-Larbi Y; Foulkes BH; Oliver-Commey J; Asiedu EK; Parker MD; Mitja O; Eggo RM; de Oliveira-Martins L; Asiedu-Bekoe F; Laryea DO; Kuma-Aboagye P; Marks M; de Silva TI; Ampofo WK
    Lancet Glob Health; 2023 Jul; 11(7):e1075-e1085. PubMed ID: 37349034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global landscape of SARS-CoV-2 genomic surveillance and data sharing.
    Chen Z; Azman AS; Chen X; Zou J; Tian Y; Sun R; Xu X; Wu Y; Lu W; Ge S; Zhao Z; Yang J; Leung DT; Domman DB; Yu H
    Nat Genet; 2022 Apr; 54(4):499-507. PubMed ID: 35347305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid genomic surveillance of SARS-CoV-2 in a dense urban community of Kathmandu Valley using sewage samples.
    Napit R; Manandhar P; Chaudhary A; Shrestha B; Poudel A; Raut R; Pradhan S; Raut S; Rajbhandari PG; Gurung A; Rajbhandari RM; Dixit SM; Schwind JS; Johnson CK; Mazet JK; Karmacharya DB
    PLoS One; 2023; 18(3):e0283664. PubMed ID: 36996055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of SARS-CoV-2 testing and genomic sequencing into influenza sentinel surveillance in Uganda, January to December 2022.
    Kayiwa JT; Nassuna C; Mulei S; Kiggundu G; Nakaseegu J; Nabbuto M; Amwine E; Nakamoga B; Nankinga S; Atuhaire P; Nabiryo P; Alunzi P; Mbaziira T; Isabirye P; Ayuro N; Owor N; Kiconco J; Bakamutumaho B; Middlebrook EA; Kaleebu P; Lutwama JJ; Bartlow AW
    Microbiol Spectr; 2023 Dec; 11(6):e0132823. PubMed ID: 37811997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global disparities in SARS-CoV-2 genomic surveillance.
    Brito AF; Semenova E; Dudas G; Hassler GW; Kalinich CC; Kraemer MUG; Ho J; Tegally H; Githinji G; Agoti CN; Matkin LE; Whittaker C; ; ; ; ; ; ; ; ; Howden BP; Sintchenko V; Zuckerman NS; Mor O; Blankenship HM; de Oliveira T; Lin RTP; Siqueira MM; Resende PC; Vasconcelos ATR; Spilki FR; Aguiar RS; Alexiev I; Ivanov IN; Philipova I; Carrington CVF; Sahadeo NSD; Branda B; Gurry C; Maurer-Stroh S; Naidoo D; von Eije KJ; Perkins MD; van Kerkhove M; Hill SC; Sabino EC; Pybus OG; Dye C; Bhatt S; Flaxman S; Suchard MA; Grubaugh ND; Baele G; Faria NR
    Nat Commun; 2022 Nov; 13(1):7003. PubMed ID: 36385137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of RT-PCR and antigen-based rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2 detection: performance, variant specificity, and clinical implications.
    Aboagye FT; Annison L; Hackman HK; Acquah ME; Ashong Y; Owusu-Frimpong I; Egyam BC; Annison S; Osei-Adjei G; Antwi-Baffour S
    Microbiol Spectr; 2024 Jun; 12(6):e0007324. PubMed ID: 38683014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
    Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
    Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Barriers to Pooled SARS-CoV-2 Testing in the United States.
    Fenichel EP; Koch RT; Gilbert A; Gonsalves G; Wyllie AL
    Microbiol Spectr; 2021 Sep; 9(1):e0031221. PubMed ID: 34378949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students.
    Bilinski A; Ciaranello A; Fitzpatrick MC; Giardina J; Shah M; Salomon JA; Kendall EA
    JAMA Pediatr; 2022 Jul; 176(7):679-689. PubMed ID: 35442396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic surveillance during the first two years of the COVID-19 pandemic - country experience and lessons learned from Türkiye.
    Yalçın S; Coşgun Y; Dedeoğlu E; Kopp K; Bayrakdar F; Ünal G; Musul B; Sağtaş E; Korukluoğlu G; Raftery P; Kaygusuz S
    Front Public Health; 2024; 12():1332109. PubMed ID: 38855447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-market surveillance of six COVID-19 point-of-care tests using pre-Omicron and Omicron SARS-CoV-2 variants.
    Exner HM; Gregorchuk BSJ; Castor A-G; Crisostomo L; Kolsun K; Giesbrecht S; Dust K; Alexander DC; Bolaji A; Quill Z; Head BM; Meyers AFA; Sandstrom P; Becker MG
    Microbiol Spectr; 2024 Jul; 12(7):e0016324. PubMed ID: 38757955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
    Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guiding the design of SARS-CoV-2 genomic surveillance by estimating the resolution of outbreak detection.
    Suster CJE; Arnott A; Blackwell G; Gall M; Draper J; Martinez E; Drew AP; Rockett RJ; Chen SC; Kok J; Dwyer DE; Sintchenko V
    Front Public Health; 2022; 10():1004201. PubMed ID: 36276383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.